Compile Data Set for Download or QSAR
Report error Found 64 Enz. Inhib. hit(s) with all data for entry = 2077
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 50069762BDBM50069762(CHEMBL3182437 | ML323 | US9802904, 87)
Affinity DataIC50: 17nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352028BDBM352028(US9802904, 89)
Affinity DataIC50: 34nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352011BDBM352011(US9802904, 72)
Affinity DataIC50: 43nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350387BDBM350387(US9802904, 60)
Affinity DataIC50: 43nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352013BDBM352013(US9802904, 74)
Affinity DataIC50: 48nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352018BDBM352018(US9802904, 79)
Affinity DataIC50: 61nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352025BDBM352025(US9802904, 86)
Affinity DataIC50: 61nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351737BDBM351737(US9802904, 61)
Affinity DataIC50: 61nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350386BDBM350386(US9802904, 59)
Affinity DataIC50: 68nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 50069762BDBM50069762(CHEMBL3182437 | ML323 | US9802904, 87)
Affinity DataIC50: 76nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351922BDBM351922(US9802904, 64)
Affinity DataIC50: 86nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350377BDBM350377(US9802904, 51)
Affinity DataIC50: 120nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350385BDBM350385(US9802904, 59)
Affinity DataIC50: 120nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352015BDBM352015(US9802904, 76)
Affinity DataIC50: 120nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351934BDBM351934(US9802904, 66)
Affinity DataIC50: 140nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351941BDBM351941(US9802904, 67)
Affinity DataIC50: 140nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350383BDBM350383(US9802904, 57)
Affinity DataIC50: 140nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351827BDBM351827(US9802904, 63)
Affinity DataIC50: 150nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350384BDBM350384(US9802904, 58)
Affinity DataIC50: 150nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352027BDBM352027(US9802904, 88)
Affinity DataIC50: 150nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352029BDBM352029(US9802904, 90)
Affinity DataIC50: 190nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351968BDBM351968(US9802904, 69)
Affinity DataIC50: 220nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350381BDBM350381(US9802904, 55)
Affinity DataIC50: 220nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352021BDBM352021(US9802904, 82)
Affinity DataIC50: 240nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350378BDBM350378(US9802904, 52)
Affinity DataIC50: 240nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351779BDBM351779(US9802904, 62)
Affinity DataIC50: 270nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350376BDBM350376(US9802904, 50)
Affinity DataIC50: 340nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352012BDBM352012(US9802904, 73)
Affinity DataIC50: 380nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351932BDBM351932(US9802904, 65)
Affinity DataIC50: 480nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350368BDBM350368(US9802904, 19)
Affinity DataIC50: 480nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350382BDBM350382(US9802904, 56)
Affinity DataIC50: 480nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352017BDBM352017(US9802904, 78)
Affinity DataIC50: 480nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350369BDBM350369(US9802904, 20 | US9802904, 21)
Affinity DataIC50: 610nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352008BDBM352008(US9802904, 70)
Affinity DataIC50: 1.10E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350365BDBM350365(US9802904, 16)
Affinity DataIC50: 1.40E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350380BDBM350380(US9802904, 54)
Affinity DataIC50: 1.50E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350367BDBM350367(US9802904, 18)
Affinity DataIC50: 1.70E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350369BDBM350369(US9802904, 20 | US9802904, 21)
Affinity DataIC50: 1.90E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350379BDBM350379(US9802904, 53)
Affinity DataIC50: 2.12E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 351954BDBM351954(US9802904, 68)
Affinity DataIC50: 2.20E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350366BDBM350366(US9802904, 17)
Affinity DataIC50: 2.20E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350371BDBM350371(US9802904, 22)
Affinity DataIC50: 2.20E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 352014BDBM352014(US9802904, 75)
Affinity DataIC50: 2.20E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350357BDBM350357(US9802904, 9)
Affinity DataIC50: 2.40E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350353BDBM350353(US9802904, 5)
Affinity DataIC50: 2.40E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350359BDBM350359(US9802904, 10)
Affinity DataIC50: 3.00E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350356BDBM350356(US9802904, 8)
Affinity DataIC50: 3.00E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350354BDBM350354(US9802904, 6)
Affinity DataIC50: 3.00E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350363BDBM350363(US9802904, 14)
Affinity DataIC50: 3.40E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services

US Patent
LigandChemical structure of BindingDB Monomer ID 350374BDBM350374(US9802904, 24)
Affinity DataIC50: 4.30E+3nMAssay Description:This example demonstrates reversible inhibition of USP1/UAF1 by an embodiment of the invention.The compound (81) at a concentration of ten times its ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2019
Entry Details
US Patent

Displayed 1 to 50 (of 64 total ) | Next | Last >>
Jump to: